NPPB and hydrops fetalis: We hypothesise that quantifying Gal-3 and NT-proBNP (NT-proBNP1-76aa and NT-proBNP13-71aa) concentrations in blood samples collected from HF patients can identify those patients at a higher risk of all-cause mortality and/or re-hospitalisations.